US Patent 7101909 Calcium channel drugs and uses
Patent 7101909 was granted and assigned to Theravance on September, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+277 characters)
Article
Patent abstract
Novel multibinding compounds are disclosed. The compounds of this invention comprise 2–10 ligands covalently connected, each of the ligands being capable of binding to a ligand binding site in a Ca++ channel, thereby modulating the biological activities thereof.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07101909 Calcium channel drugs and uses US Patent 7101909 Calcium channel drugs and uses
Infobox
Patent Number
0710190900
Patent Number
710190900
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071019090
Date of Patent
September 5, 2006
0Patent Application Number
108773680
Date Filed
June 25, 2004
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071019090
Date of Patent
September 5, 2006
0Patent Application Number
108773680
Date Filed
June 25, 2004
0Official Website
Patent Primary Examiner
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07101909 Calcium channel drugs and uses
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07101909
Date of patent
September 5, 2006
Patent application number
10877368
Date Filed
June 25, 2004
Patent primary examiner
Find more entities like US Patent 7101909 Calcium channel drugs and uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
